Enisamium iodide is a derivative of isonicotinic acid. Its systematic chemical name is N-benzyl-1-methylpyridin-1-ium-4-carboxamide iodide, from which the shortened name carbabenzpiride is sometimes used. It is a registered antiviral drug sold in Ukraine, Kazakhstan, Mongolia, Belarus and other Eastern European countries under the trade names Amizon, Amizon Max and Amizonchik. In 2019 the World Health Organization assigned it the ATC code J05AX17, for antivirals for systemic use of direct action, and included it in the ATC/DDD index. This entry records what the source lead states and is not medical advice.
Facts
Classification
Approval Status ATC ClassJ: Antiinfectives for Systemic Use 2 Sources
1. Enisamium iodide (Wikipedia)
Lead paragraph
Enisamium iodide is a registered antiviral drug sold in Ukraine
Lead paragraph [drug-kind]
J05AX17 (Antivirals for systemic use of direct action)
View the Source2. WHO Collaborating Centre for Drug Statistics Methodology, ATC/DDD Index: the WHO ATC/DDD Index entries named Enisamium iodide
WHO Collaborating Centre for Drug Statistics Methodology, ATC/DDD IndexATC/DDD Index entry; ATC class derived from cited code J05AX17 (main group J)Quote, ATC/DDD Index entry; ATC class derived from cited code J05AX17 (main group J)
J05AX17 enisamium iodide
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.